PUT - SPRINTER OPEN END - MERCK & CO. Share Price

Certificat

DE000VM9N4C9

Delayed Deutsche Boerse AG 16:03:16 13/05/2024 BST
1.66 EUR +11.41% Intraday chart for PUT - SPRINTER OPEN END - MERCK & CO.
Current month-2.61%
1 month-18.58%
Date Price Change Volume
13/05/24 1.66 +11.41% 0
10/05/24 1.49 -1.32% 0
09/05/24 1.51 -2.58% 0
08/05/24 1.55 -4.91% 0
07/05/24 1.63 -6.32% 0

Delayed Quote Deutsche Boerse AG

Last update May 13, 2024 at 04:03 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM9N4C
ISINDE000VM9N4C9
Date issued 02/02/2024
Strike 145.8 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.9
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.39
Lowest since issue 1.21
Spread 0.01
Spread %0.59%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.1 USD
Average target price
141.6 USD
Spread / Average Target
+8.90%
Consensus